ABOUT US

Key executives

Overview

Biosimilar Pharmaceuticals

Sales and Marketing

Manufacturing
Business Development

Key executives

Scientific Advisory Board

 






Adam Wilczega
Non-Executive Director


Mr. Wilczega is the President of the Management Board and General Manager of Polish listed company Bioton S.A. He presided over Bioton during the development and implementation of the production of recombinant human insulin. Bioton is the fourth company worldwide and the first in Poland to produce biosynthetic insulin for industrial purposes. Mr Wilczega was formerly a director at the Varimex Foreign Trade Company and between 1984 and 1989 was delegated as director to the Commercial and Technical Centre in Cairo.
 
   
  back